4.7 Article

Prices and clinical benefit of cancer drugs in the USA and Europe: a cost–benefit analysis

Journal

LANCET ONCOLOGY
Volume 21, Issue 5, Pages 664-670

Publisher

Elsevier BV
DOI: 10.1016/s1470-2045(20)30139-x

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available